Valneva SE (VALN) Cash from Investing Activities (2021 - 2026)

Valneva SE's (VALN) quarterly Cash from Investing Activities came in at $321955.1 in Q1 2026, up 131.85% year-on-year from $138863.8 in Q1 2025, and up 204.77% quarter-over-quarter from -$307307.5 in Q4 2025.

Valneva SE (VALN) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Cash from Investing Activities across 6 years of filings, most recently posting $321955.1 for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $321955.1, up 131.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$525913.1 (up 95.59% YoY), and the FY2025 annual result was -$2.0 million, down 102.42% from the prior year.
  • Cash from Investing Activities came in at $321955.1 for Q1 2026 at Valneva SE, up from -$307307.5 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7.2 billion in Q3 2023 to a low of -$7.2 billion in Q2 2023.
  • The 5-year median for Cash from Investing Activities is -$1.0 million (2025), against an average of $1.6 million.
  • Peak annual rise in Cash from Investing Activities reached 110357.31% in 2023, while the deepest fall reached 103203.17% in 2023.
  • Valneva SE's Cash from Investing Activities stood at -$6.7 million in 2022, then slumped by 161.86% to -$17.6 million in 2023, then soared by 128.54% to $5.0 million in 2024, then plunged by 106.13% to -$307307.5 in 2025, then jumped by 204.77% to $321955.1 in 2026.
  • The last three Cash from Investing Activities figures came in at $321955.1 (Q1 2026), -$307307.5 (Q4 2025), and $230303.9 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.89 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -431.90 Mn
9 Abivax 94.26 Bn 94.26 Bn - 579,519.10
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 321,955.05

Historic Data

Download Data
DateValue
Mar 31, 2026 321,955.05
Mar 31, 2026 321,955.05
Dec 31, 2025 -307,307.49
Dec 31, 2025 -307,307.49
Sep 30, 2025 230,303.85
Sep 30, 2025 230,303.85
Jun 30, 2025 -770,864.55
Jun 30, 2025 -770,864.55
Mar 31, 2025 -1.01 Mn
Mar 31, 2025 -1.01 Mn
Dec 31, 2024 5.01 Mn
Dec 31, 2024 5.01 Mn
Sep 30, 2024 -16.89 Mn
Sep 30, 2024 -16.89 Mn
Jun 30, 2024 963,814.38
Jun 30, 2024 963,814.38
Mar 31, 2024 94.20 Mn
Mar 31, 2024 94.20 Mn
Dec 31, 2023 -17.56 Mn
Dec 31, 2023 -17.56 Mn